Jefferies Cuts Estimates But Lifts PT on The Medicines Co (MDCO) Post Q4
Tweet Send to a Friend
Jefferies raised its price target on Buy-rated The Medicines Company (NASDAQ: MDCO) from $34 to $36 following a beat on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
